Trends in the Epidemiology of Brucellosis Cases in Iran During the Last Decade

Overview

Journal Iran J Public Health

Date 2023 Feb 6

PMID 36742247

Authors

Mohammad Zeinali

Sara Doosti

Behzad Amiri

Mohammad Mehdi Gouya

Gidiglo Nutifafa Godwin

Affiliations

Soon will be listed here.

Abstract

Background: Brucellosis is one of the most important zoonotic diseases that impose a serious public health burden on some countries in the world. Annually, the WHO reports more than 500000 new cases of human brucellosis. The disease is endemic in most parts of Iran; especially, in areas where people live in close contact with infected animals. According to data from the Iranian Ministry of Health, the average incidence of brucellosis in Iran was 22 cases per 100000 population, with a decreasing trend of surveillance.

Methods: This cross-sectional survey was carried out within 2011-2020 in all provinces of Iran and from patients with clinical symptoms.

Results: During the last decade, a total of 173526 cases were reported from different provinces of Iran, with a higher frequency of occurrence in males (58.2%) living in rural areas (77%), as compared to those in urban areas (23%). Moreover, brucellosis was more common in the summer season (June) and most of the cases were via contact with infected livestock (91%) and consumption of unpasteurized dairy products (78% in rural areas and 76% in the urban areas).

Conclusion: The failure to effectively control brucellosis may be attributed to lack of knowledge about the disease, consumption of unpasteurized dairy and raw meat, lack of proper and safe vaccines for prevention and eradication programs, lack of rapid detection systems, and ineffective methods of isolating infected animals. Therefore, education and advancement of people's knowledge are key to the prevention and control of the disease.

Citing Articles

Some zoonotic infectious diseases are prevalent among children under 15 years of age in Ardabil Province, northern Iran.

Mohebali M, Akhoundi B, Asfaram S, Zarei Z, Modares-Sadrani S, Noori N BMC Infect Dis. 2025; 25(1):244.

PMID: 39984836 PMC: 11844169. DOI: 10.1186/s12879-025-10605-2.

Spatio-temporal analysis of human brucellosis distribution in Neyshabur, Iran from 2015 to 2022, a cross-sectional study.

Fathabadi A, Khorashadizadeh F, Darrudi R, Maroosi M PLoS One. 2025; 20(2):e0318503.

PMID: 39965002 PMC: 11835317. DOI: 10.1371/journal.pone.0318503.

Social network analysis of key stakeholders in Brucellosis prevention in Western Iran.

Behzadifar M, Yarahmadi M, Bakhtiari A, Kargar S, Shahabi S, Azari S Trop Med Health. 2025; 53(1):18.

PMID: 39910632 PMC: 11800574. DOI: 10.1186/s41182-025-00693-w.

Epidemiology of brucellosis in Mazandaran, North of Iran in a nine-year period (2009-2017).

Salmani Seraji M, Yazdani Charati J, Baba Mahmoudi F, Ali Mohammadpour Tahamtan R, Vahedi H, Shojaei J Caspian J Intern Med. 2024; 15(4):666-672.

PMID: 39359437 PMC: 11444106. DOI: 10.22088/cjim.15.4.666.

Human Brucellosis in Iraq: Spatiotemporal Data Analysis From 2007-2018.

Mustafa A, Khaleel H, Lami F JMIRx Med. 2024; 5:e54611.

PMID: 38967413 PMC: 11317540. DOI: 10.2196/54611.

References

Zeinalian Dastjerdi M, Fadaei Nobari R, Ramazanpour J . Epidemiological features of human brucellosis in central Iran, 2006-2011. Public Health. 2012; 126(12):1058-62. DOI: 10.1016/j.puhe.2012.07.001. View

Pappas G . The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents. 2010; 36 Suppl 1:S8-11. DOI: 10.1016/j.ijantimicag.2010.06.013. View

Al Dahouk S, Neubauer H, Hensel A, Schoneberg I, Nockler K, Alpers K . Changing epidemiology of human brucellosis, Germany, 1962-2005. Emerg Infect Dis. 2008; 13(12):1895-900. PMC: 2876757. DOI: 10.3201/eid1312.070527. View

Sofian M, Aghakhani A, Velayati A, Banifazl M, Eslamifar A, Ramezani A . Risk factors for human brucellosis in Iran: a case-control study. Int J Infect Dis. 2007; 12(2):157-61. DOI: 10.1016/j.ijid.2007.04.019. View

Seleem M, Boyle S, Sriranganathan N . Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2009; 140(3-4):392-8. DOI: 10.1016/j.vetmic.2009.06.021. View

Bagheri H, Tapak L, Karami M, Amiri B, Cheraghi Z . Epidemiological Features of Human Brucellosis in Iran (2011-2018) and Prediction of Brucellosis with Data-Mining Models. J Res Health Sci. 2020; 19(4):e00462. PMC: 7183567. View

Mirnejad R, Masjedian Jazi F, Mostafaei S, Sedighi M . Epidemiology of brucellosis in Iran: A comprehensive systematic review and meta-analysis study. Microb Pathog. 2017; 109:239-247. DOI: 10.1016/j.micpath.2017.06.005. View

Delvecchio V, Kapatral V, Redkar R, Patra G, Mujer C, Los T . The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci U S A. 2002; 99(1):443-8. PMC: 117579. DOI: 10.1073/pnas.221575398. View

Kassiri H, Amani H, Lotfi M . Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran. Asian Pac J Trop Biomed. 2013; 3(8):589-94. PMC: 3703550. DOI: 10.1016/S2221-1691(13)60121-5. View

10.

Kayaaslan B, Bastug A, Aydin E, Akinci E, But A, Aslaner H . A long-term survey of brucellosis: Is there any marker to predict the complicated cases?. Infect Dis (Lond). 2015; 48(3):215-21. DOI: 10.3109/23744235.2015.1107187. View

11.

Pappas G, Akritidis N, Bosilkovski M, Tsianos E . Brucellosis. N Engl J Med. 2005; 352(22):2325-36. DOI: 10.1056/NEJMra050570. View

12.

Tiller R, Gee J, Frace M, Taylor T, Setubal J, Hoffmaster A . Characterization of novel Brucella strains originating from wild native rodent species in North Queensland, Australia. Appl Environ Microbiol. 2010; 76(17):5837-45. PMC: 2935067. DOI: 10.1128/AEM.00620-10. View

13.

Mesner O, Riesenberg K, Biliar N, Borstein E, Bouhnik L, Peled N . The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis. 2008; 45(12):e135-40. DOI: 10.1086/523726. View

14.

Nabavi M, Hatami H, Jamaliarand H . Epidemiological, Risk Factors, Clinical, and Laboratory Features of Brucellosis in the Southwest of Iran within 2009-2015. Int J Prev Med. 2019; 10:108. PMC: 6592108. DOI: 10.4103/ijpvm.IJPVM_14_18. View

15.

Minas M, Minas A, Gourgulianis K, Stournara A . Epidemiological and clinical aspects of human brucellosis in Central Greece. Jpn J Infect Dis. 2007; 60(6):362-6. View

16.

Refai M . Incidence and control of brucellosis in the Near East region. Vet Microbiol. 2002; 90(1-4):81-110. DOI: 10.1016/s0378-1135(02)00248-1. View

17.

Moosazadeh M, Nikaeen R, Abedi G, Kheradmand M, Safiri S . Epidemiological and Clinical Features of People with Malta Fever in Iran: A Systematic Review and Meta-Analysis. Osong Public Health Res Perspect. 2016; 7(3):157-67. PMC: 4927669. DOI: 10.1016/j.phrp.2016.04.009. View

18.

Al-Tawfiq J, AbuKhamsin A . A 24-year study of the epidemiology of human brucellosis in a health-care system in Eastern Saudi Arabia. J Infect Public Health. 2010; 2(2):81-5. DOI: 10.1016/j.jiph.2009.03.003. View

19.

Franco M, Mulder M, Gilman R, Smits H . Human brucellosis. Lancet Infect Dis. 2007; 7(12):775-86. DOI: 10.1016/S1473-3099(07)70286-4. View

20.

Memish Z, Balkhy H . Brucellosis and international travel. J Travel Med. 2004; 11(1):49-55. DOI: 10.2310/7060.2004.13551. View